We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

LeukoDx, GE Healthcare Enter Agreement

News   Mar 26, 2016

 
LeukoDx, GE Healthcare Enter Agreement
 
 
 

RELATED ARTICLES

Decoding Pancreatic Cancer’s Invade and Evade Tactics

News

Two known gene mutations induce pathways that enhance pancreatic cancer's ability to invade tissues and evade the immune system. Researchers now report on the molecular details of this process, shining a light on potential druggable targets for immunotherapies.

READ MORE

Treatment Takes a "BiTE" Out of Brain Cancer

News

Investigators have created a new method that could make immune therapy more effective against brain tumors and expand its use against other types of solid tumors.

READ MORE

Case Study Identifies Encephalitis As Rare Toxicity of Immunotherapy Treatment

News

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at investigated why the complication occurred, performing a molecular analysis of the disease’s pathology and mining data to determine the incidence of similar occurrences.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE